𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Once-Yearly Zoledronic Acid for Treatment of Postmenopausal Osteoporosis

✍ Scribed by Black, Dennis M.; Delmas, Pierre D.; Eastell, Richard; Reid, Ian R.; Boonen, Steven; Cauley, Jane A.; Cosman, Felicia; Lakatos, Péter; Leung, Ping Chung; Man, Zulema

Book ID
111901737
Publisher
Massachusetts Medical Society
Year
2007
Tongue
English
Weight
510 KB
Volume
356
Category
Article
ISSN
0096-6762

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bone material properties in actively bon
Bone material properties in actively bone-forming trabeculae in postmenopausal women with osteoporosis after three years of treatment with once-yearly Zoledronic acid
✍ Sonja Gamsjaeger; Birgit Buchinger; Elizabeth Zwettler; Robert Recker; Dennis Bl 📂 Article 📅 2010 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 473 KB

Zoledronic acid (ZOL), a third-generation aminobisphosphonate, showed pronounced antifracture efficacy in a phase III clinical trial [Health Outcomes and Reduced Incidence with Zoledronic Acid Once Yearly-Pivotal Fracture Trial (HORIZON-PFT)] when administered yearly (5-mg infusions of ZOL), produci